ALLMedicine™ Papillomavirus Center

May 6th, 2021 - To determine the prevalence, viral load, tissue tropism, and genetic variability of novel human papillomavirus (HPV) type 179, which is etiologically associated with sporadic cases of common warts in immunocompromised patients, and phylogeneticall...

May 5th, 2021 - Human papillomavirus (HPV) is recognized as a major cause of oropharyngeal cancer (OPC) in Western countries. Less is known regarding its contribution to the OPC occurring in Asia. The current study aimed to investigate the association between ant...

May 5th, 2021 - Recent modifications in the epidemiology of oropharyngeal squamous cell carcinoma (OSCC) have led to the increase of Human papillomavirus (HPV) related metastatic head and neck cancer patients with high life expectancy even at advanced stage, low ...

May 5th, 2021 - Human leukocyte antigen (HLA)-G may have an important role in the natural history of human papillomavirus (HPV) infection. Our aim was to evaluate the role of HLA-G in the outcome of genital and oral HPV infections in women. Analyses included 306 ...

May 4th, 2021 - In the U.S., human papillomavirus (HPV) vaccination has been recommended for individuals up to age 26, although the vaccination is currently approved for all people up to the age of 45. This research sought to explore HPV vaccination disparities b...

Aug 9th, 2020 - To compare the proportion of cervical intraepithelial neoplasia (CIN) 2 or worse pathology among different risk strata according to the ASCCP when applied in women who had atypical squamous cells of undetermined significance (ASC-US) or low-grade ...

Jul 31st, 2020 - Human papillomavirus (HPV) causes significant morbidity and mortality in women and men. The HPV vaccine significantly reduces the incidence of anogenital cancer and genital warts in women and in men. Human papillomavirus vaccines are among the mos...

Jul 8th, 2020 - The American Cancer Society (ACS) presents an adaptation of the current Advisory Committee on Immunization Practices recommendations for human papillomavirus (HPV) vaccination. The ACS recommends routine HPV vaccination between ages 9 and 12 years...

Jun 3rd, 2020 - European Federation for Colposcopy (EFC) and European Society of Gynaecological Oncology (ESGO) joint considerations about human papillomavirus (HPV) vaccination, screening programs, colposcopy, and surgery during and after the COVID-19 pandemic.|...

May 29th, 2020 - The final results of the randomized phase II ECOG-ACRIN E3311 trial were presented by Robert L. Ferris, MD, PhD, and colleagues during the ASCO20 Virtual Scientific Program (Abstract 6500) and in today's Head and Neck Cancer Oral Abstract Session....

May 9th, 2021 - Although head and neck cancers include multiple histologies and primary sites, squamous cell carcinomas (SCC) originating in the oropharynx, oral cavity, larynx, or hypopharynx are the most common. Today, we recognize different types of head and n...

May 6th, 2021 - To determine the prevalence, viral load, tissue tropism, and genetic variability of novel human papillomavirus (HPV) type 179, which is etiologically associated with sporadic cases of common warts in immunocompromised patients, and phylogeneticall...

May 5th, 2021 - Human papillomavirus (HPV) is recognized as a major cause of oropharyngeal cancer (OPC) in Western countries. Less is known regarding its contribution to the OPC occurring in Asia. The current study aimed to investigate the association between ant...

May 5th, 2021 - Recent modifications in the epidemiology of oropharyngeal squamous cell carcinoma (OSCC) have led to the increase of Human papillomavirus (HPV) related metastatic head and neck cancer patients with high life expectancy even at advanced stage, low ...

May 5th, 2021 - Human leukocyte antigen (HLA)-G may have an important role in the natural history of human papillomavirus (HPV) infection. Our aim was to evaluate the role of HLA-G in the outcome of genital and oral HPV infections in women. Analyses included 306 ...

Apr 26th, 2021 - Although vaccination rates against the human papillomavirus (HPV) remain low for young adults across the United States, the number of self-reported HPV vaccinations among women and men between the ages of 18 and 21 years has markedly increased sin...

Feb 28th, 2021 - A trial of an at-home human papillomavirus (HPV) swab test has begun in London, United Kingdom, as part of an initiative to increase uptake of cervical screening. The trial will involve 31,000 women aged 25–64 years who are either 15 months overdu...

Jan 10th, 2021 - Having oral sex with more than 10 previous partners was associated with a 4.3 times' greater likelihood of developing human papillomavirus (HPV)–related oropharyngeal cancer, according to new findings. The study also found that having more partner...

Nov 16th, 2020 - (Reuters Health) - Interventions in schools and primary care clinics to increase human papillomavirus (HPV) vaccine uptake can be cost-effective, a new analysis suggests. Researchers looked at three different year-long interventions to increase HP...

Nov 16th, 2020 - (Reuters Health) - Interventions in schools and primary care clinics to increase human papillomavirus (HPV) vaccine uptake can be cost-effective, a new analysis suggests. Researchers looked at three different year-long interventions to increase HP...